Trust Co. of Virginia VA increased its position in shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 200.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,813 shares of the financial services provider’s stock after purchasing an additional 6,542 shares during the period. Trust Co. of Virginia VA’s holdings in iShares NASDAQ Biotechnology Index were worth $1,048,000 at the end of the most recent reporting period.
Other hedge funds have also recently made changes to their positions in the company. FNY Partners Fund LP purchased a new position in shares of iShares NASDAQ Biotechnology Index in the 3rd quarter worth $133,000. Wharton Business Group LLC purchased a new position in shares of iShares NASDAQ Biotechnology Index in the 3rd quarter worth $208,000. New England Investment & Retirement Group Inc. purchased a new position in shares of iShares NASDAQ Biotechnology Index in the 3rd quarter worth $213,000. Flow Traders U.S. LLC purchased a new position in shares of iShares NASDAQ Biotechnology Index in the 3rd quarter worth $263,000. Finally, Davidson & Garrard Inc. boosted its stake in shares of iShares NASDAQ Biotechnology Index by 30.1% during the 3rd quarter. Davidson & Garrard Inc. now owns 877 shares of the financial services provider’s stock worth $293,000 after purchasing an additional 203 shares during the period. Hedge funds and other institutional investors own 61.47% of the company’s stock.
iShares NASDAQ Biotechnology Index (NASDAQ:IBB) traded down $0.14 during mid-day trading on Wednesday, hitting $113.78. 1,550,000 shares of the company were exchanged, compared to its average volume of 3,610,000. iShares NASDAQ Biotechnology Index has a 52-week low of $94.20 and a 52-week high of $119.30. The stock has a market cap of $9,700.00, a PE ratio of 3.76 and a beta of 1.38.
TRADEMARK VIOLATION WARNING: This news story was first posted by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this news story on another site, it was copied illegally and reposted in violation of international copyright & trademark law. The correct version of this news story can be read at https://stocknewstimes.com/2018/03/14/trust-co-of-virginia-va-boosts-stake-in-ishares-nasdaq-biotechnology-index-ibb.html.
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.